Targeting Biological Aging: A New Paradigm For 21st Century Medicine

In this episode:

Intro (0:00)
Rapamycin (2:42)
Animal Studies & Rapamycin (5:47)
Top Longevity Interventions (12:27)
Rapamycin & COVID (16:43)
Focusing On Longevity VS Disease (20:53)
Interventions To Maximize Longevity (26:18)
Other Longevity Interventions (35:42)
Longevity Supplements (47:31)
Measuring Biological Age (54:36)
Research Genie Question (1:01:46)

TODAY´S EPISODE IS BROUGHT TO YOU BY THE FLOW RESEARCH COLLECTIVE

Are you an entrepreneur, a leader, or a knowledge worker, who wants to harness the power of flow so you can get more done in less time with greater ease and accomplish your boldest professional goals faster? If you´ve answered this question with “hell yes” then our peak-performance training Zero to Dangerous may be a good fit for you. If this sounds of interest to you all you need to do is click here right now, pop in your application and one of our team members will be in touch with you very soon.

ABOUT THE GUEST:

Matt Kaeberlein is an American biologist and biogerontologist best known for his research on evolutionarily conserved mechanisms of aging. He is currently a professor of pathology at the University of Washington in Seattle, where he began as an assistant professor at UW in 2006, an associate professor in 2011, and a full professor in 2015. He has received several awards for his work, including a Breakthroughs in Gerontology Award, an Alzheimer's Association New Investigator Award, and an Ellison Medical Foundation New Scholar in Aging Award. In 2011, he was named the Vincent Cristofalo Rising Star in Aging Research by the American Federation for Aging Research and appointed as a GSA Fellow. Kaeberlein was also recognized as an Undergraduate Research Mentor of the Year in 2010.

RESOURCES

STEVEN KOTLER is a New York Times bestselling author, award-winning journalist, and Founder and Executive Director of the Flow Research Collective. He is one of the world’s leading experts on human performance.

His books include The Art of Impossible, Stealing Fire, and The Rise of Superman. His work has been translated into over 40 languages and appeared in over 100 publications, including the New York Times Magazine, Wall Street Journal, TIME, Wired, Atlantic Monthly, The Harvard Business Review and Forbes.

‍